Fecal Microbiome Transplant
Fecal Microbiome Transplant in Pediatric C. Difficile
Sponsor: Judith Kelsen
This observational or N/A phase trial investigates Clostridium Difficile and Crohn's Disease and is currently ongoing. Judith Kelsen leads this study, which shows 15 recorded versions since 2015 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
15 versions recorded-
Apr 16, 2026 — Present [daily]
Enrolling By Invitation
Phase: PHASE1 → None
-
Apr 2025 — Apr 2026 [monthly]
Enrolling By Invitation PHASE1
Status: Recruiting → Enrolling By Invitation
-
Sep 2024 — Apr 2025 [monthly]
Recruiting PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE1
-
Mar 2024 — Jul 2024 [monthly]
Recruiting PHASE1
Phase: NA → PHASE1
▶ Show 10 earlier versions
-
May 2023 — Mar 2024 [monthly]
Recruiting NA
Status: Active Not Recruiting → Recruiting
-
May 2022 — May 2023 [monthly]
Active Not Recruiting NA
-
May 2021 — May 2022 [monthly]
Active Not Recruiting NA
-
Jan 2021 — May 2021 [monthly]
Active Not Recruiting NA
-
May 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Feb 2020 — May 2020 [monthly]
Recruiting NA
-
Jan 2019 — Feb 2020 [monthly]
Recruiting NA
-
Jun 2018 — Jan 2019 [monthly]
Recruiting NA
-
Feb 2017 — Jun 2018 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Dec 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
Fecal Microbiota Transplant (FMT) in pediatric patients with recurrent C. Difficile with or without Inflammatory Bowel Disease (IBD) The aims of this study are to determine the safety and efficacy of FMT treatment in pediatric patients with recurrent or moderate to severe C. Difficile without (through an observational study) and with (through a clinical trial) Inflammatory Bowel Disease and to determine the effect of FMT on the gut microbiota through the use of 454 pyrosequencing before and after transplantation in these patients.
Contact Information
- Judith Kelsen
For direct contact, visit the study record on ClinicalTrials.gov .